Market Overview

The China digital health market size was valued at USD 81.3 billion in 2024. The market is projected to reach USD 328.8 billion by 2033, growing at a CAGR of 16.8% during the forecast period of 2025-2033. This growth is driven by technological advancements, government support, and rising demand for telemedicine, AI diagnostics, and health applications that enhance healthcare accessibility and quality. 

Study Assumption Years

• Base Year: 2024
• Historical Years: 2019-2024
• Forecast Period: 2025-2033

China Digital Health Market Key Takeaways

• The China digital health market size reached USD 81.3 billion in 2024.
• The market is expected to grow at a CAGR of 16.8% from 2025 to 2033.
• The forecast period spans from 2025 to 2033.
• The market is expanding due to technological innovations, increased government initiatives, and a surge in demand for telehealth and AI-powered healthcare tools.
• Market growth has accelerated with increased investments in digital healthcare infrastructure across China.
• The COVID-19 pandemic significantly boosted telemedicine adoption, exemplified by over 2700 approved Internet hospitals and 363 million online medical service users by 2022.
• Government policies such as "Internet plus Healthcare" facilitate integration of internet technologies with traditional healthcare to improve efficiency and accessibility.

Sample Request Link: 

https://www.imarcgroup.com/China-Digital-Health-Market/requestsample

Market Growth Factors

The growth of the China digital health market is primarily fueled by substantial government initiatives and policies. A major government strategy involves promoting "Internet plus Healthcare," which integrates internet technologies with traditional healthcare services, enhancing accessibility and efficiency in the healthcare system. This initiative supports online consultations, remote diagnostics, and digital management of health records, making healthcare more reachable. Following the COVID-19 outbreak, the market witnessed a surge in telemedicine, with China approving 2700 Internet hospitals and gaining a user base of approximately 363 million for online medical services by the end of 2022. The market sizes for Internet hospitals and online pharmacies reached around RMB 310 billion and RMB 250 billion, reflecting year-on-year increases of 39% and 36% respectively. These policies illustrate the government's commitment to modernizing China's healthcare infrastructure.

Artificial intelligence (AI) and big data integration are revolutionizing healthcare delivery across China. AI accelerates drug development by speeding up compound identification and optimizing clinical trials. The establishment of the CR-BU Joint Innovation Center on Smart Chinese Medicine highlights progress in chronic disease management and AI research tailored to traditional Chinese medicine. AI-powered diagnostics analyze medical images to detect diseases such as cancer at early stages with increased accuracy, and personalized treatment plans utilize patient-specific data for improved outcomes. Big data enables comprehensive health management by aggregating extensive health records that aid predictive analysis and outbreak identification, thereby supporting research and innovative treatment development.

Investment surges in digital healthcare infrastructure and innovative health tech solutions also underpin market growth. The increasing government and private sector expenditure on developing digital healthcare platforms expands telemedicine, AI diagnostics, and medical apps, enriching healthcare accessibility nationwide. The rise in online medical services indicates a shift towards digitized care pathways, improving service quality and efficiency. This rapid infrastructure development ensures that more patients, especially in remote or underserved areas, gain access to advanced healthcare services, fostering equal health opportunities and elevating overall care standards across China.

Request Customization:

https://www.imarcgroup.com/request?type=report&id=23446&flag=E 

Market Segmentation

Type Insights:

• Telehealth: Driven by government support and pandemic-induced demand, telehealth enables remote access to healthcare through online consultations and digital platforms, improving accessibility across diverse regions.
• Medical Wearables: These devices facilitate continuous health monitoring, contributing to personalized care and real-time health data collection.
• EMR/EHR Systems: Electronic medical and health records systems digitize patient data, enabling efficient health information management and interoperability across healthcare providers.
• Medical Apps: Health-related applications enhance patient engagement, medication management, and health education.
• Healthcare Analytics: Utilizes data to support decision-making, disease prediction, and healthcare optimization.
• Others: Additional digital health solutions complement core technologies, supporting the ecosystem.

Component Insights:

• Software: Encompasses applications and platforms essential for telehealth, data management, diagnostics, and analytics.
• Hardware: Includes devices such as medical wearables and infrastructure equipment necessary for service delivery.
• Service: Involves consulting, support, and implementation services facilitating the adoption and maintenance of digital health technologies.

Regional Insights

The report segments China into North China, East China, South Central China, Southwest China, Northwest China, and Northeast China. Though specific market share percentages are not provided, the analysis indicates these regions are key to the country's digital health market development and adoption, each contributing to the overall growth through infrastructure expansion and government policy implementation.

Recent Developments & News

In 2024, London-based telehealth company QuestPrehab signed an exclusive contract with IHSN Healthcare to provide digital prehabilitation services to pulmonary patients in China. This scalable and cost-efficient platform aims to improve patient outcomes without requiring changes to existing healthcare infrastructure. Also in 2024, China Medical University Hospital partnered with Google Cloud to deploy MedLM, a generative AI designed for cancer care, assisting in diagnosis, treatment planning, patient education, and research. The hospital also implemented AI-powered services like the Intelligent Anti-Microbial System, underscoring the growing role of AI in healthcare advancement.

Competitive Landscape

The competitive landscape of the industry has also been examined along with the profiles of the key players.

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group,

134 N 4th St. Brooklyn, NY 11249, USA,

Email: sales@imarcgroup.com,

Tel No: (D) +91 120 433 0800,

United States: +1-201971-6302